Under construction – not a live service
Sign in

NCT02917369Recruiting

Integrative Analysis of Large-cell Lung Cancer

LCLC · Run by Shanghai 10th People's Hospital

Integrative Analysis of Large-cell Lung Carcinoma

Source: ClinicalTrials.gov · Last updated 28 Sept 2016 · Not updated for over 12 months - ask the site whether it is still open

Next steps

Brief summary (registry, in English)

Integrative analysis of LCLC

Status (registry)
Recruiting
Study type
Observational
Enrollment
1000 (estimated)
First submitted
27 Sept 2016
Start date
Jan 2016
Primary completion date
Dec 2026
Lead sponsor
Shanghai 10th People's Hospital
Diseases
Lung cancer
NCT number
NCT02917369

What you commit to

  • Study type: Observational
  • Planned participants: 1000
  • From Jan 2016 to the primary completion date, Dec 2026
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults up to 75 years old with large-cell lung cancer confirmed by tissue examination. They must be in good general health and must not have had chemotherapy.

Age
18 to 75 years
Sex
All sexes can join.
Disease stage
Large-cell lung cancer (LCLC) confirmed by tissue examination. WHO performance status of 0 or 1.
Earlier treatment
No earlier cancer chemotherapy.

Main reasons for not taking part

  • Age 76 or older
  • Severe major organ dysfunction
  • WHO performance status above 1
  • Earlier cancer chemotherapy

Read by machine on 9 Nov 2026.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Prior cancer chemotherapy

Age

  • Age ≥ 76

Other

  • Severe major organ dysfunction
  • WHO performance status of >1

Who the study is looking for

  • Age ≤ 75 years with histologically proven LCLC
  • No severe major organ dysfunction
  • World Health Organization (WHO) performance status of 0 or 1
  • No prior cancer chemotherapy

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Ganzhou City People's HospitalGanzhouChinaRecruiting
Shanghai Tenth People's HospitalShanghaiChinaRecruiting
Shanghai Pulmonary HospitalShanghaiChinaRecruiting

Are you the coordinator? Confirm the details

The registry text, word for word

This page is information, not medical advice. Discuss any trial with your doctor.